DRREDDY's weekly performance was disappointing, with a return of -1.38% and a Sharpe Ratio of -0.20, indicating poor risk-adjusted returns. The stock's volatility was moderate at 27.21%, which is lower than DIVISLAB but higher than SUNPHARMA and HINDUNILVR. Compared to its peers, DRREDDY underperformed DIVISLAB and SUNPHARMA, but outperformed HINDUNILVR. Overall, the stock was moderately risky this week, with a Max Drawdown of -3.48%.

[Volatility: 27.21%]